Literature DB >> 18616559

Mechanisms and consequences of bladder cell invasion by uropathogenic Escherichia coli.

B K Dhakal1, R R Kulesus, M A Mulvey.   

Abstract

Strains of uropathogenic Escherichia coli (UPEC) are the major cause of urinary tract infections worldwide. Multiple studies over the past decade have called into question the dogmatic view that UPEC strains act as strictly extracellular pathogens. Rather, bacterial expression of filamentous adhesive organelles known as type 1 pili and Afa/Dr fibrils enable UPEC to invade host epithelial cells within the urinary tract. Entry into bladder epithelial cells provides UPEC with a protected niche where the bacteria can persist quiescently for long periods, unperturbed by host defences and protected from many antibiotic treatments. Alternately, internalized UPEC can rapidly multiply, forming large intracellular inclusions that can contain several thousand bacteria. Initial work aimed at defining the host and bacterial factors that modulate the entry, intracellular trafficking, and eventual resurgence of UPEC suggests a high degree of host-pathogen crosstalk. Targeted disruption of these processes may provide a novel means to prevent and treat recurrent, relapsing and chronic infections within the urinary tract.

Entities:  

Mesh:

Year:  2008        PMID: 18616559     DOI: 10.1111/j.1365-2362.2008.01986.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  42 in total

1.  Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.

Authors:  Matthew G Blango; Matthew A Mulvey
Journal:  Antimicrob Agents Chemother       Date:  2010-03-15       Impact factor: 5.191

2.  Antibacterial effects of nitric oxide on uropathogenic Escherichia coli during bladder epithelial cell colonization--a comparison with nitrofurantoin.

Authors:  Ravi Vumma; Charlotte Sahlberg Bang; Robert Kruse; Kjell Johansson; Katarina Persson
Journal:  J Antibiot (Tokyo)       Date:  2015-11-04       Impact factor: 2.649

Review 3.  Who's really in control: microbial regulation of protein trafficking in the epithelium.

Authors:  Matthew R Hendricks; Jennifer M Bomberger
Journal:  Am J Physiol Cell Physiol       Date:  2013-10-16       Impact factor: 4.249

Review 4.  Amplifying renal immunity: the role of antimicrobial peptides in pyelonephritis.

Authors:  Brian Becknell; Andrew Schwaderer; David S Hains; John David Spencer
Journal:  Nat Rev Nephrol       Date:  2015-07-07       Impact factor: 28.314

5.  UPEC hemolysin: more than just for making holes.

Authors:  Sheryl S Justice; David A Hunstad
Journal:  Cell Host Microbe       Date:  2012-01-19       Impact factor: 21.023

6.  Proteus mirabilis fimbriae- and urease-dependent clusters assemble in an extracellular niche to initiate bladder stone formation.

Authors:  Jessica N Schaffer; Allison N Norsworthy; Tung-Tien Sun; Melanie M Pearson
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-04       Impact factor: 11.205

7.  Persistence of uropathogenic Escherichia Coli in the bladders of female patients with sterile urine after antibiotic therapies.

Authors:  Shu-Cheng Liu; Xiao-Min Han; Ming Shi; Zi-Li Pang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-10-18

8.  The Cpx stress response system potentiates the fitness and virulence of uropathogenic Escherichia coli.

Authors:  Irina Debnath; J Paul Norton; Amelia E Barber; Elizabeth M Ott; Bijaya K Dhakal; Richard R Kulesus; Matthew A Mulvey
Journal:  Infect Immun       Date:  2013-02-19       Impact factor: 3.441

9.  Biomimetic delivery strategies at the urothelium: targeted cytoinvasion in bladder cancer cells via lectin bioconjugates.

Authors:  Lukas Neutsch; Britta Eggenreich; Ela Herwig; Martina Marchetti-Deschmann; Günter Allmaier; Franz Gabor; Michael Wirth
Journal:  Pharm Res       Date:  2013-12-24       Impact factor: 4.200

10.  Use of zebrafish to probe the divergent virulence potentials and toxin requirements of extraintestinal pathogenic Escherichia coli.

Authors:  Travis J Wiles; Jean M Bower; Michael J Redd; Matthew A Mulvey
Journal:  PLoS Pathog       Date:  2009-12-18       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.